1. Home
  2. SUPN vs TRMD Comparison

SUPN vs TRMD Comparison

Compare SUPN & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$48.78

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo TORM plc

TRMD

TORM plc

N/A

Current Price

$27.70

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
TRMD
Founded
2005
1889
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
SUPN
TRMD
Price
$48.78
$27.70
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$61.60
$34.00
AVG Volume (30 Days)
706.9K
1.0M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
N/A
Revenue This Year
$23.19
N/A
Revenue Next Year
$17.65
N/A
P/E Ratio
N/A
$9.61
Revenue Growth
N/A
N/A
52 Week Low
$29.16
$13.63
52 Week High
$59.68
$31.76

Technical Indicators

Market Signals
Indicator
SUPN
TRMD
Relative Strength Index (RSI) 40.56 56.55
Support Level $47.95 $21.54
Resistance Level $52.14 $31.76
Average True Range (ATR) 1.99 0.91
MACD -0.58 -0.17
Stochastic Oscillator 21.81 67.09

Price Performance

Historical Comparison
SUPN
TRMD

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About TRMD TORM plc

TORM plc operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.

Share on Social Networks: